Study of Interactions between Metallothionein and Cisplatin by using Differential Pulse Voltammetry Brdickás reaction and Quartz Crystal Microbalance

. 2009 ; 9 (3) : 1355-69. [epub] 20090226

Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid22573958

Treatment strategies for tumour diseases are progressively focusing on personalization of medicine. However, this focus requires methods revealing the early general biological mechanisms, including the formation anti-cancer drugs' resistance. The low molecular mass protein metallothionein is thought to be the crucial for the formation of resistance in tumour treatment based on the platinum-cytostatics. The interactions between metallothionein (MT) and cisplatin were determined by the adsorptive transfer stripping technique coupled with the differential pulse votlammetry Brdickás reaction. The signals related to the MT-cisplatin complex appeared at -0.9 V. The formation of this complex depended on the time of interaction between cisplatin and MT. The complex formation was consequently confirmed by quartz crystal microbalance analyses. The formation of this complex was detectable even after a 20 s long interaction. Moreover, we detected presence of MT-cisplatin complex in the blood of male rats treated with this drug.

Zobrazit více v PubMed

Kagi J.H.R., Schaffer A. Biochemistry of Metallothionein. Biochemistry. 1988;27:8509–8515. PubMed

Miles A.T., Hawksworth G.M., Beattie J.H., Rodilla V. Induction, regulation, degradation, and biological significance of mammalian metallothioneins. Crit. Rev. Biochem. Mol. Biol. 2000;35:35–70. PubMed

Kukacka J., Tesfaye H., Malis J., Adam V., Fabrik I., Kotaska K., Stary J., Kizek R., Prusa R. Carboblatin monitoring by flameless atomic absorption spectrophotometry and metallothionein levels in pediatric patients with solid tumors. Clin. Chem. 2008;54:A11–A11.

Zhang B.L., Sun W.Y., Tang W.X. Determination of the association constant of platinum(II) to metallothionein. J. Inorg. Biochem. 1997;65:295–298.

Huska D., Krizkova S., Beklova M., Havel L., Zehnalek J., Diopan V., Adam V., Zeman L., Babula P., Kizek R. Influence of cadmium(II) ions and brewery sludge on metallothionein level in earthworms (Eisenia fetida) - Biotransforming of toxic wastes. Sensors. 2008;8:1039–1047. PubMed PMC

Prusa R., Petrlova J., Kukacka J., Adam V., Sures B., Beklova M., Kizek R. Study of interaction of glutathiones and metallothionein with cytostatics. Clin. Chem. 2006;52:A175–A175.

Prusa R., Blastik O., Kukacka J., Zehnalek J., Adam V., Petrlova J., Kizek R. The influence of platinum-based drugs on the amount of metallothionein. Toxicol. Lett. 2005;158:S66–S67.

Prusa R., Blastik O., Kukacka J., Kizek R., Stuchlikova H. Plasma metallothionein levels in lead poisoned child. Toxicol. Lett. 2005;158:S156–S157.

Diopan V., Baloun J., Adam V., Macek T., Havel L., Kizek R. Determination of expression of metallothionein at transgenic tobacco plants. Lis. Cukrov. Repar. 2007;123:325–327.

Supalkova V., Beklova M., Baloun J., Singer C., Sures B., Adam V., Huska D., Pikula J., Rauscherova L., Havel L., Zehnalek J., Kizek R. Affecting of aquatic vascular plant Lemna minor by cisplatin revealed by voltammetry. Bioelectrochemistry. 2008;72:59–65. PubMed

Krizkova S., Fabrik I., Adam V., Kukacka J., Prusa R., Chavis G.J., Trnkova L., Strnadel J., Horak V., Kizek R. Utilizing of adsorptive transfer stripping technique Brdicka reaction for determination of metallothioneins level in melanoma cells, blood serum and tissues. Sensors. 2008;8:3106–3122. PubMed PMC

Eckschlager T., Adam V., Hrabeta J., Figova K., Kizek R. Metallothioneins and cancer. Curr. Protein Pept. Sci. 2009 in press. PubMed

Lobinski R., Chassaigne H., Szpunar J. Analysis for metallothioneins using coupled techniques. Talanta. 1998;46:271–289. PubMed

Sestakova I., Navratil T. Voltammetric methods in metallothionein research. Bioinorg. Chem. Appl. 2005;3:43–53. PubMed PMC

Szpunar J. Bio-inorganic speciation analysis by hyphenated techniques. Analyst. 2000;125:963–988. PubMed

Szpunar J., Lobinski R., Prange A. Hyphenated techniques for elemental speciation in biological systems. Appl. Spectrosc. 2003;57:102A–112A. PubMed

Chassaigne H., Lobinski R. Characterization of metallothionein isoforms by reversed-phase high-performance liquid chromatography with on-line post-column acidification and electrospray mass spectrometric detection. J. Chromatogr. A. 1998;829:127–136. PubMed

Chassaigne H., Lobinski R. Characterization of horse kidney metallothionein isoforms by electrospray MS and reversed-phase HPLC-electrospray MS. Analyst. 1998;123:2125–2130. PubMed

Chassaigne H., Lobinski R. Polymorphism and identification of metallothionein isoforms by reversed-phase HPLC with on-line ion spray mass spectrometric detection. Anal. Chem. 1998;70:2536–2543. PubMed

Kizek R., Trnkova L., Palecek E. Determination of metallothionein at the femtomole level by constant current stripping chronopotentiometry. Anal. Chem. 2001;73:4801–4807. PubMed

Fabrik I., Krizkova S., Huska D., Adam V., Hubalek J., Trnkova L., Eckschlager T., Kukacka J., Prusa R., Kizek R. Employment of electrochemical techniques for metallothionein determination in tumor cell lines and patients with a tumor disease. Electroanalysis. 2008;20:1521–1532.

Adam V., Blastik O., Krizkova S., Lubal P., Kukacka J., Prusa R., Kizek R. Application of the Brdicka reaction in determination of metallothionein in patients with tumours. Chem. Listy. 2008;102:51–58.

Lim D., Koh J., Yip G., Tan P., Bay B. Metallothionein as a potential molecular target in breast cancer. Breast. 2007;16:S16–S16. PubMed

El Sharkarvy S.L., Farrag A.R.H. Mean nuclear area and metallothionein expression in ductal breast tumors: Correlation with estrogen receptor status. Appl. Immunohistochem. 2008;16:108–112. PubMed

Liu Z.M., Chen G.G., Shum C.K.Y., Vlantis A.C., Cherlan M.G., Koropatnick J., van Hasselta C.A. Induction of functional MT1 and MT2 isoforms by calcium in anaplastic thyroid carcinoma cells. FEBS Lett. 2007;581:2465–2472. PubMed

Ferrario C., Lavagni P., Gariboldi M., Miranda C., Losa M., Cleris L., Formelli F., Pilotti S., Pierotti M.A., Greco A. Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma. Lab. Invest. 2008;88:474–481. PubMed

Albrecht A.L., Singh R.K., Somji S., Sens M.A., Sens D.A., Garrett S.H. Basal and metal-induced expression of metallothionein isoform 1 and 2 genes in the RWPE-1 human prostate epithelial cell line. J. Appl. Toxicol. 2008;28:283–293. PubMed

Yamasaki M., Nomura T., Sato F., Mimata H. Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells. Oncol. Rep. 2007;18:1145–1153. PubMed

Athanassiadou P., Bantis A., Gonidi M., Athanassiades P., Agelonidou E., Grapsa D., Nikolopoulou P., Patsouris E. The expression of metallothioneins on imprint smears of prostate carcinoma: Correlation with clinicopathologic parameters and tumor proliferative capacity. Tumori. 2007;93:189–194. PubMed

Lee S.S., Yang S.F., Ho Y.C., Tsai C.H., Chang Y.C. The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Oncol. 2008;44:180–186. PubMed

Liu Y.B., Li L.N., Gao Y.X., Chen C.Y., Li B., He W., Huang Y.Y., Chai Z.F. Distribution of metalloproteins in hepatocellular carcinoma and surrounding tissues. Hepato-Gastroenterol. 2007;54:2291–2296. PubMed

Tao X., Zheng J.M., Xu A.M., Chen X.F., Zhang S.H. Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma. Hepatol. Res. 2007;37:820–827. PubMed

Wang D., Lippard S.J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 2005;4:307–320. PubMed

Chaney S.G., Campbell S.L., Temple B., Bassett E., Wu Y.B., Faldu M. Protein interactions with platinum-DNA adducts: from structure to function. J. Inorg. Biochem. 2004;98:1551–1559. PubMed

Krizkova S., Adam V., Petrlova J., Zitka O., Stejskal K., Zehnalek J., Sures B., Trnkova L., Beklova M., Kizek R. A suggestion of electrochemical biosensor for study of platinum(II)-DNA interactions. Electroanalysis. 2007;19:331–338.

Petrlova J., Potesil D., Zehnalek J., Sures B., Adam V., Trnkova L., Kizek R. Cisplatin electrochemical biosensor. Electrochim. Acta. 2006;51:5169–5173.

Krizkova S., Zitka O., Adam V., Beklova M., Horna A., Svobodova Z., Sures B., Trnkova L., Zeman L., Kizek R. Possibilities of electrochemical techniques in metallothionein and lead detection in fish tissues. Czech J. Anim. Sci. 2007;52:143–148.

Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer. 2007;7:573–584. PubMed

Timerbaev A.R., Hartinger C.G., Aleksenko S.S., Keppler B.K. Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology. Chem. Rev. 2006;106:2224–2248. PubMed

Baik M.H., Friesner R.A., Lippard S.J. Theoretical study of cisplatin binding to purine bases: Why does cisplatin prefer guanine over adenine? J. Am. Chem. Soc. 2003;125:14082–14092. PubMed

Burda J.V., Zeizinger M., Leszczynski J. Hydration process as an activation of trans- and cisplatin complexes in anticancer treatment. DFT and ab initio computational study of thermodynamic and kinetic parameters. J. Comput. Chem. 2005;26:907–914. PubMed

Zimmermann T., Zeizinger M., Burda J.V. Cisplatin interaction with cysteine and methionine, a theoretical DFT study. J. Inorg. Biochem. 2005;99:2184–2196. PubMed

Adam V., Baloun J., Fabrik I., Trnkova L., Kizek R. An electrochemical detection of metallothioneins at the zeptomole level in nanolitre volumes. Sensors. 2008;8:2293–2305. PubMed PMC

Petrlova J., Krizkova S., Zitka O., Hubalek J., Prusa R., Adam V., Wang J., Beklova M., Sures B., Kizek R. Utilizing a chronopotentiometric sensor technique for metallothionein determination in fish tissues and their host parasites. Sens. Actuat. B-Chem. 2007;127:112–119.

Adam V., Beklova M., Pikula J., Hubalek J., Trnkova L., Kizek R. Shapes of differential pulse voltammograms and level of metallothionein at different animal species. Sensors. 2007;7:2419–2429. PubMed PMC

Adam V., Hanustiak P., Krizkova S., Beklova M., Zehnalek J., Trnkova L., Horna A., Sures B., Kizek R. Palladium biosensor. Electroanalysis. 2007;19:1909–1914.

Huska D., Zitka O., Adam V., Beklova M., Krizkova S., Zeman L., Horna A., Havel L., Zehnalek J., Kizek R. A sensor for investigating the interaction between biologically important heavy metals and glutathione. Czech J. Anim. Sci. 2007;52:37–43.

Adam V., Krizkova S., Zitka O., Trnkova L., Petrlova J., Beklova M., Kizek R. Determination of apo-metallothionein using adsorptive transfer stripping technique in connection with differential pulse voltammetry. Electroanalysis. 2007;19:339–347.

Petrlova J., Potesil D., Mikelova R., Blastik O., Adam V., Trnkova L., Jelen F., Prusa R., Kukacka J., Kizek R. Attomole voltammetric determination of metallothionein. Electrochim. Acta. 2006;51:5112–5119.

Adam V., Petrlova J., Potesil D., Zehnalek J., Sures B., Trnkova L., Jelen F., Kizek R. Study of metallothionein modified electrode surface behavior in the presence of heavy metal ions-biosensor. Electroanalysis. 2005;17:1649–1657.

Grieshaber D., MacKenzie R., Voros J., Reimhult E. Electrochemical biosensors - Sensor principles and architectures. Sensors. 2008;8:1400–1458. PubMed PMC

Lucarelli F., Tombelli S., Minunni M., Marrazza G., Mascini M. Electrochemical and piezoelectric DNA biosensors for hybridisation detection. Anal. Chim. Acta. 2008;609:139–159. PubMed

Sassolas A., Leca-Bouvier B.D., Blum L.J. DNA biosensors and microarrays. Chem. Rev. 2008;108:109–139. PubMed

Cooper M.A., Singleton V.T. A survey of the 2001 to 2005 quartz crystal microbalance biosensor literature: applications of acoustic physics to the analysis of biomolecular interactions. J. Mol. Recognit. 2007;20:154–184. PubMed

Olafson R.W., Sim R.G. Electrochemical Approach to Quantitation and Characterization of Metallothioneins. Anal. Biochem. 1979;100:343–351. PubMed

Raspor B. Elucidation of the mechanism of the Brdicka reaction. J. Electroanal. Chem. 2001;503:159–162.

Raspor B., Paic M., Erk M. Analysis of metallothioneins by the modified Brdicka procedure. Talanta. 2001;55:109–115. PubMed

El Hourch M., Dudoit A., Amiard J.C. Optimization of new voltammetric method for the determination of metallothionein. Electrochim. Acta. 2003;48:4083–4088.

El Hourch M., Dudoit A., Amiard J.C. An optimization procedure for determination of metallothionein by square wave cathodic stripping voltammetry: application to marine worms. Anal. Bioanal. Chem. 2004;378:776–781. PubMed

Knipp M., Karotki A.V., Chesnov S., Natile G., Sadler P.J., Brabec V., Vasak M. Reaction of Zn(7)Metallothionein with cis- and trans-[Pt(N-donor)(2)Cl-2] anticancer complexes: trans-Pt-II complexes retain their N-donor ligands. J. Med. Chem. 2007;50:4075–4086. PubMed

Romero-Isart N., Vasak M. Advances in the structure and chemistry of metallothioneins. J. Inorg. Biochem. 2002;88:388–396. PubMed

Zhang B.L., Huang H., Tang W.X. Interaction of Cis-Diamminedichloroplatinum and Trans-Diamminedichloroplatinum with Metallothionein in-Vivo. J. Inorg. Biochem. 1995;58:1–8. PubMed

Kizek R., Vacek J., Trnkova L., Jelen F. Cyclic voltammetric study of the redox system of glutathione using the disulfide bond reductant tris(2-carboxyethyl)phosphine. Bioelectrochemistry. 2004;63:19–24. PubMed

Murphy S., Boyle F.M., Davey R.A., Gu X.Q., Mather L.E. Enantioselectivity of thalidomide serum and tissue concentrations in a rat glioma model and effects of combination treatment with cisplatin and BCNU. J. Pharm. Pharmacol. 2007;59:105–114. PubMed

Krizkova S., Fabrik I., Adam V., Kukacka J., Prusa R., Trnkova L., Strnadel J., Horak V., Kizek R. Effects of reduced glutathione, surface active agents and ionic strength on detection of metallothioneins by using of Brdicka reaction. Electroanalysis. 2009;21:640–644.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...